Serum Institute of India Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Serum Institute of India Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10795
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Serum Institute of India Ltd (Serum Institute) is a biotechnology company that manufactures and markets vaccines and immuno-biologicals. The company offers products such as bacterial vaccines, viral vaccines, recombinant and combination vaccines, polysaccharide conjugate vaccines, meningococcal A conjugate vaccine, pharma products, anti cancer products and anti sera, plasma and influenza vaccines, among others. Its technological advancement include robotic arm for virus handling, cell factory and cell cube for growing cells, facilities for the manufacture of polysaccharide and recombinant vaccines and for monoclonal antibodies. Serum Institute utilizes latest technology screeners to inspect its products for any minute particulate matter undetectable to the normal human eye. It has operations in Chennai, Kolkatta, New Delhi, Surat, Trivandrum and Visakhapatnam. Serum Institute is headquartered in Pune, Maharashtra, India.

Serum Institute of India Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Serum Institute of India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Serum Institute of India Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Serum Institute of India Acquires Production Facilities Of Netherlands Vaccine Institute For US$40 Million 12
Venture Financing 13
Visterra Raises Additional USD23.6 Million in Series C Financing 13
Private Equity 15
Serum Institute Plans to Sell Minority Stake in Itself 15
Partnerships 16
Serum Institute of India Enters into Licensing Agreement with St. Jude Children’s Research Hospital 16
IAVI and Serum Institute of India Enter into Development Partnership 17
Panacea Biotec Enters into Agreement with Serum Institute of India 18
Cipla Enters into Distribution Agreement with Serum Institute 19
Cipla Enters into Distribution Agreement with Serum Institute of India 20
Licensing Agreements 21
Serum Institute of India Enters into Licensing Agreement with Visterra 21
Serum Institute Expands Licensing Agreement with Genkyotex 22
Genticel Enters into Licensing Agreement with Serum Institute of India 23
Serum Institute of India Enters into Licensing Agreement with NeuClone 24
Nanolek Enters into Licensing Agreement with Bilthoven Biologicals for IPV Vaccine 25
Serum Institute of India Enters Into Licensing Agreement With Vakzine Projekt Management For VPM1002 26
Equity Offering 27
Xenetic Biosciences Raises USD0.3 Million in Private Placement of Shares 27
Acquisition 28
Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 28
Serum Institute Of India Acquires Bilthoven Biologicals, Monoclonal Antibodies And Vaccine Maker, For US$101 Million 29
Serum Institute Plans To Sell Its Stake In Akorn 30
Serum Institute of India Ltd – Key Competitors 32
Serum Institute of India Ltd – Key Employees 33
Serum Institute of India Ltd – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Product News 35
May 24, 2018: Serum Institute To Develop vaccine to fight Nipah Virus 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Serum Institute of India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Serum Institute of India Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Serum Institute of India Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Serum Institute of India Acquires Production Facilities Of Netherlands Vaccine Institute For US$40 Million 12
Visterra Raises Additional USD23.6 Million in Series C Financing 13
Serum Institute Plans to Sell Minority Stake in Itself 15
Serum Institute of India Enters into Licensing Agreement with St. Jude Children’s Research Hospital 16
IAVI and Serum Institute of India Enter into Development Partnership 17
Panacea Biotec Enters into Agreement with Serum Institute of India 18
Cipla Enters into Distribution Agreement with Serum Institute 19
Cipla Enters into Distribution Agreement with Serum Institute of India 20
Serum Institute of India Enters into Licensing Agreement with Visterra 21
Serum Institute Expands Licensing Agreement with Genkyotex 22
Genticel Enters into Licensing Agreement with Serum Institute of India 23
Serum Institute of India Enters into Licensing Agreement with NeuClone 24
Nanolek Enters into Licensing Agreement with Bilthoven Biologicals for IPV Vaccine 25
Serum Institute of India Enters Into Licensing Agreement With Vakzine Projekt Management For VPM1002 26
Xenetic Biosciences Raises USD0.3 Million in Private Placement of Shares 27
Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 28
Serum Institute Of India Acquires Bilthoven Biologicals, Monoclonal Antibodies And Vaccine Maker, For US$101 Million 29
Serum Institute Plans To Sell Its Stake In Akorn 30
Serum Institute of India Ltd, Key Competitors 32
Serum Institute of India Ltd, Key Employees 33
Serum Institute of India Ltd, Other Locations 34
Serum Institute of India Ltd, Subsidiaries 34

List of Figures
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Serum Institute of India Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Serum Institute of India Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QHR Corporation:医療機器:M&Aディール及び事業提携情報
    Summary QHR Corporation (QHR), a subsidiary of Shoppers Drug Mart Inc. (SDMI), formerly known as QHR Technologies Inc., is a healthcare technology provider. It offers electronic medical records (EMR) for healthcare professionals including family physicians, medical specialists, and surgeons. The com …
  • MemorialCare Health System:製薬・医療:M&Aディール及び事業提携情報
    Summary MemorialCare Health System (MemorialCare) is a non-profit health system that offers medical services. The center offers care services such as stroke care, cancer care, rehabilitation and physical therapy, weight-loss surgery, heart and vascular care, breast care, imaging and radiology, labor …
  • Ariel Corporation:企業の戦略的SWOT分析
    Ariel Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Mobidiag Ltd.:(医療機器分野)企業M&A及び提携動向
    Summary Mobidiag Ltd. (Mobidiag) is a biotechnology service company. It develops and manufactures products on microarray based Prove-it technology for the early detection and diagnosis of pathogenic microbes that causing severe infections. The company’s products include Amplidiag Bacterial GE, a sol …
  • Tata Elxsi Limited (TATAELXSI):企業の財務及び戦略的SWOT分析
    Summary Tata Elxsi Limited (Tata Elxsi), a subsidiary of Tata Sons Ltd. is a technology service provider that provides technology consulting, new product development, system integration and testing services. The company offers solutions such as automated test solution, DVB middleware, home media gat …
  • Wavefront Technology Solutions, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Wavefront Technology Solutions, …
  • Eurus Energy Holdings Corp:電力:M&Aディール及び事業提携情報
    Summary Eurus Energy Holdings Corp (Eurus Energy), a subsidiary of Toyota Tsusho Corporation, is a renewable energy company that generates power through various renewable sources such as wind and solar photovoltaic. The company's services include location survey, wind or sunlight study, basic design …
  • Suntory Beverage & Food Limited:企業の戦略・SWOT・財務分析
    Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report Summary Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • vTv Therapeutics Inc (VTVT):企業のM&A・提携動向(医療分野)
    Summary vTv Therapeutics Inc (vTv) is a clinical stage pharmaceutical company that discovers, develops and commercializes small molecule drug candidates. Its pipeline products are used for treatment of central nervous system disorders, metabolic disorders, inflammatory diseases and cancer. The lead …
  • Neoenergia S.A.:企業のM&A・提携動向(発電分野)
    Summary Neoenergia S.A. (Neoenergia) is an electric utility company that offers electricity generation, transmission, distribution and trading of electricity. The company generates electricity through fuel source, including thermal; hydro; and wind power plants. It serves consumer units in Bahia, Pe …
  • Cidara Therapeutics Inc (CDTX):企業の財務・戦略的SWOT分析
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida in …
  • Iino Kaiun Kaisha, Ltd. (9119):企業の財務及び戦略的SWOT分析
    Summary Iino Kaiun Kaisha, Ltd. (Iino Kaiun) is a maritime transportation company that provides shipping and real estate business. The company offers shipping services through oil tankers, chemical tankers, large gas carriers, small gas carriers and dry bulk carriers. It provides office leasing, bui …
  • Apceth GmbH & Co. KG:製品開発パイプライン動向2015
    Apceth GmbH & Co. KG - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Apceth GmbH & Co. KG - Product Pipeline Review - 2015’, provides an overview of the Apceth GmbH & Co. KG’s pharmaceutical research and development focus. This report provides comprehensive information on the curr …
  • Hyland Software, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hyland Software, Inc. Mergers a …
  • Sierra Nevada Corporation:企業の戦略・SWOT・財務情報
    Sierra Nevada Corporation - Strategy, SWOT and Corporate Finance Report Summary Sierra Nevada Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sun Pharmaceutical Industries Limited (SUNPHARMA):企業の財務及び戦略的SWOT分析
    Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Mount Tam Biotechnologies Inc (MNTM):企業の財務・戦略的SWOT分析
    Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that offers development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamycin analog …
  • The Goldman Sachs Group, Inc.:企業の戦略・SWOT・財務分析
    SummaryThe Goldman Sachs Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Toleranzia AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Toleranzia AB (Toleranzia) is a drug developer that utilizes immune system’s intrinsic power to treat autoimmune diseases. The company offers products and technologies including Re-Tolerogen for the treatment of autoimmune diseases. Its Re-Tolerogen platform technology is a fusion protein fo …
  • Janssen R&D Ireland(製薬・医療分野):企業M&A動向
    Summary Janssen R&D Ireland (Janssen) is a pharmaceutical company. The company discovers and develops innovative therapeutic and diagnostic solutions for the treatment of life-threatening infectious diseases. Janssen’s therapeutic areas include cardiovascular and metabolism, immunology, infectious d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆